Skip to main content

Gout News

Research Highlights
01/14/2026
Jessica Garlewicz
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links...
01/14/2026
Rheumatology & Arthritis
News
09/15/2025
Riya Gandhi, MA
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched...
09/15/2025
Rheumatology & Arthritis
News
09/15/2025
Riya Gandhi, MA
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a...
09/15/2025
Rheumatology & Arthritis
Research Highlights
09/15/2025
Riya Gandhi, MA
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social...
09/15/2025
Rheumatology & Arthritis
News
09/04/2025
Rebecca Mashaw
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily...
09/04/2025
Rheumatology & Arthritis
News
08/26/2025
Riya Gandhi, MA
A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
A post-hoc analysis of a 72-week...
08/26/2025
Rheumatology & Arthritis
News
08/26/2025
Riya Gandhi, MA
A large, matched cohort study using U.S. Veterans Health Administration data found that patients with gout are significantly more likely to receive chronic opioid prescriptions than those without gout—particularly among underserved...
A large, matched cohort study using U.S. Veterans Health Administration data found that patients with gout are significantly more likely to receive chronic opioid prescriptions than those without gout—particularly among underserved...
A large, matched cohort study...
08/26/2025
Rheumatology & Arthritis
News
07/29/2025
Jessica Garlewicz
These results could support plant-based dietary patterns and highlight a potential role for the gut microbiome in modulating gout risk.
These results could support plant-based dietary patterns and highlight a potential role for the gut microbiome in modulating gout risk.
These results could support...
07/29/2025
Rheumatology & Arthritis
News
06/24/2025
Jessica Garlewicz
For rheumatologists, these findings suggest that monthly dosing of pegloticase with MTX may offer a more patient-friendly regimen without compromising therapeutic outcomes, particularly for those with uncontrolled gout requiring long-term...
For rheumatologists, these findings suggest that monthly dosing of pegloticase with MTX may offer a more patient-friendly regimen without compromising therapeutic outcomes, particularly for those with uncontrolled gout requiring long-term...
For rheumatologists, these...
06/24/2025
Rheumatology & Arthritis
Research Highlights
06/24/2025
Jessica Garlewicz
Given the known cardiovascular burden among patients with gout, these findings may prompt changes in prophylaxis prescribing practices to prioritize long-term cardiovascular safety.
Given the known cardiovascular burden among patients with gout, these findings may prompt changes in prophylaxis prescribing practices to prioritize long-term cardiovascular safety.
Given the known cardiovascular...
06/24/2025
Rheumatology & Arthritis